Pfizer and BioNTech applied to the Food and Drug Administration (FDA) for full approval of their COVID-19 vaccine.  More than 134 million doses of Pfizer’s vaccine have already been administered across the U.S. under an emergency use authorization (EUA), according to the Centers for Disease Control and Prevention (CDC). Similarly, more than 109 million doses